[en] BACKGROUND Liver extracellular volume (L-ECV), a novel cardiac magnetic resonance (CMR) parameter of systemic venous congestion, might help to stratify tricuspid regurgitation (TR) patients at higher risk, but its role in this context is unexplored. OBJECTIVES The aim of this study was to assess the incremental prognostic relevance of L-ECV in a large TR cohort. METHODS Data were collected from patients with TR referred to CMR between 2019 and 2024 who had parametric mapping analysis for L-ECV quantification. The primary endpoint was the composite of all-cause mortality and heart failure (HF) hospitalization, under medical management. RESULTS In 462 patients included (median age: 67 years; 43% female), median left ventricular ejection fraction was 51% (Q1-Q3: 40%-59%), median tricuspid regurgitant fraction was 21% (Q1-Q3: 14%-33%), and median L-ECV was 31% (Q1-Q3: 28%-35%). When dividing the cohort according to median L-ECV value, patients with high L-ECV ($ median) showed worse baseline status with more clinical and imaging signs of right HF and (after a median follow-up of 2.1 years) poorer survival free from the primary outcome (P < 0.001) compared with patients with low L-ECV. High L-ECV independently predicted the outcome even after multivariable adjustment accounting for TR severity, biventricular ejection fraction, and pulmonary pressure (adjusted HR: 1.82; 95% CI: 1.03-3.18; P = 0.030). Finally, L-ECV showed incremental prognostic value compared with TRI-SCORE when assessed in a nested Cox model. CONCLUSIONS In our large real-world TR cohort, L-ECV appeared as a novel, powerful CMR marker of right HF with an independent and incremental prognostic value to stratify patients with TR at higher risk of events.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Margonato, Davide ; Cardiovascular Imaging Research Center, Minneapolis Heart Institute Foundation, Minneapolis, USA ; Cardiovascular Imaging Unit and Cardiology Department, Cardiothoracic Department, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy
Nishihara, Takahiro; Cardiovascular Imaging Research Center, Minneapolis Heart Institute Foundation, Minneapolis, USA
Fukui, Miho ; Cardiovascular Imaging Research Center, Minneapolis Heart Institute Foundation, Minneapolis, USA
Okada, Atsushi ; Cardiovascular Imaging Research Center, Minneapolis Heart Institute Foundation, Minneapolis, USA
Vignale, Davide; Clinical and Experimental Radiology Unit, Experimental Imaging Center, IRCCS San Raffaele Hospital, Milan, Italy
Esposito, Antonio; Clinical and Experimental Radiology Unit, Experimental Imaging Center, IRCCS San Raffaele Hospital, Milan, Italy
Benfari, Giovanni; Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy
Agricola, Eustachio; Cardiovascular Imaging Unit and Cardiology Department, Cardiothoracic Department, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy
Praz, Fabien ; University Hospital Bern Inselspital, University of Bern, Bern, Switzerland
Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation
Badano, Luigi; Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Italy ; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Muraru, Denisa; Department of Cardiology, Istituto Auxologico Italiano, IRCCS, Italy ; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy
Modine, Thomas; Hôpital haut Lévêque, Unite Médico Chirurgicale, Centre Hospitalier Universitaire de Bordeaux
Hausleiter, Jӧrg
Hahn, Rebecca
Dreyfus, Julien
Messika-Zeitoun, David
Bapat, Vinayak
Donal, Erwan
Metra, Marco; Cardiovascular Imaging Unit and Cardiology Department, Cardiothoracic Department, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy
Enriquez-Sarano, Maurice ; Cardiovascular Imaging Research Center, Minneapolis Heart Institute Foundation, Minneapolis, USA
Cavalcante, João; Cardiovascular Imaging Research Center, Minneapolis Heart Institute Foundation, Minneapolis, USA
Enriquez-Sarano, M., Messika-Zeitoun, D., Topilsky, Y., Tribouilloy, C., Benfari, G., Michelena, H., Tricuspid regurgitation is a public health crisis. Prog Cardiovasc Dis 62:6 (2019), 447–451, 10.1016/j.pcad.2019.10.009.
Essayagh, B., Antoine, C., Benfari, G., et al. Functional tricuspid regurgitation of degenerative mitral valve disease: a crucial determinant of survival. Eur Heart J 41:20 (2020), 1918–1929, 10.1093/eurheartj/ehaa192.
Benfari, G., Antoine, C., Miller, W.L., et al. Excess mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction. Circulation 140:3 (2019), 196–206, 10.1161/CIRCULATIONAHA.118.038946.
Otto, C.M., Nishimura, R.A., Bonow, R.O., et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 77:4 (2021), e25–e197, 10.1016/j.jacc.2020.11.018.
Praz, F., Borger, M.A., Lanz, J., et al., ESC/EACTS Scientific Document Group. 2025 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J, 29, 2025, ehaf194, 10.1093/eurheartj/ehaf194.
Dreyfus, J., Audureau, E., Bohbot, Y., et al. TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery. Eur Heart J 43:7 (2022), 654–662, 10.1093/eurheartj/ehab679.
Dreyfus, J., Galloo, X., Taramasso, M., et al. TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation. Eur Heart J 45:8 (2024), 586–597, 10.1093/eurheartj/ehad585.
Gaspardone, C., Morosato, M., Braccischi, F., et al. Heart valve center approach to severe tricuspid regurgitation: real-world data and outcomes. Can J Cardiol 41:10 (2025), 2014–2023, 10.1016/j.cjca.2025.06.069.
Hahn, R.T., Badano, L., Praz, F., et al. The last decade in tricuspid regurgitation: how imaging shaped a field. JACC Cardiovasc Imaging 18:9 (2025), 1013–1041, 10.1016/j.jcmg.2025.03.003.
Zhan, Y., Debs, D., Khan, M.A., et al. Natural history of functional tricuspid regurgitation quantified by cardiovascular magnetic resonance. J Am Coll Cardiol 76:11 (2020), 1291–1301, 10.1016/j.jacc.2020.07.036.
Myerson, S.G., CMR in evaluating valvular heart disease: diagnosis, severity, and outcomes. JACC Cardiovasc Imaging 14:10 (2021), 2020–2032, 10.1016/j.jcmg.2020.09.029.
Cavalcante, J.L., Scherer, M., Fukui, M., et al. Advanced imaging assessment of the impact of tricuspid regurgitation on cardiac remodeling: the TRILUMINATE pivotal imaging substudy. J Am Coll Cardiol 85:3 (2025), 250–261, 10.1016/j.jacc.2024.09.009.
Innocenzi, A., Rangel, I., Póvoa-Corrêa, M., et al. Cardiac and liver fibrosis assessed by multiparametric MRI in patients with fontan circulation. Pediatr Cardiol 46:4 (2025), 966–975, 10.1007/s00246-024-03522-9.
Bergamaschi, L., Arangalage, D., Maurizi, N., et al. Hepatic T1 mapping as a novel cardio-hepatic axis imaging biomarker early after ST-elevation myocardial infarction. Eur Heart J Cardiovasc Imaging 26:2 (2025), 229–238, 10.1093/ehjci/jeae256.
Wang, J., Diao, Y., Xu, Y., et al. Liver T1 mapping derived from cardiac magnetic resonance imaging: a potential prognostic marker in idiopathic dilated cardiomyopathy. J Magn Reson Imaging 60:2 (2024), 675–685, 10.1002/jmri.29223.
Margonato, D., Enriquez-Sarano, M., Fukui, M., et al. Quantitative tricuspid regurgitation assessment by cardiac magnetic resonance: novel insights. Eur Heart J Cardiovasc Imaging, 15, 2025, jeaf289, 10.1093/ehjci/jeaf289.
Margonato, D., Enriquez-Sarano, M., Nishihara, T., et al. Quantitative identification of high-risk tricuspid regurgitation by cardiac magnetic resonance. Circulation 152:25 (2025), 1769–1780, 10.1161/CIRCULATIONAHA.125.074862.
Villar-Calle, P., Zhang, R.S., Naami, E., et al. Hepatic extracellular volume fraction by CMR: a novel prognostic marker in tricuspid regurgitation. Circ Cardiovasc Imaging, 19(3), 2026, e018988, 10.1161/CIRCIMAGING.125.018988.
Lancellotti, P., Pibarot, P., Chambers, J., et al. Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper. Eur Heart J Cardiovasc Imaging 23:5 (2022), e171–e232, 10.1093/ehjci/jeab253.
Lang, R.M., Badano, L.P., Mor-Avi, V., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1 (2015), 1–39.e14, 10.1016/j.echo.2014.10.003.
Schulz-Menger, J., Bluemke, D.A., Bremerich, J., et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance—2020 update: society for Cardiovascular Magnetic Resonance (SCMR): board of trustees task force on standardized post-processing. J Cardiovasc Magn Reson, 22(1), 2020, 19, 10.1186/s12968-020-00610-6.
Fine, N.M., Tandon, S., Kim, H.W., et al. Validation of sub-segmental visual scoring for the quantification of ischemic and nonischemic myocardial fibrosis using late gadolinium enhancement MRI. J Magn Reson Imaging 38:6 (2013), 1369–1376, 10.1002/jmri.24116.
Hahn, R.T., Lawlor, M.K., Davidson, C.J., et al. Tricuspid valve academic research consortium definitions for tricuspid regurgitation and trial endpoints. J Am Coll Cardiol 82:17 (2023), 1711–1735, 10.1016/j.jacc.2023.08.008.
Wang, N., Fulcher, J., Abeysuriya, N., et al. Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis. Eur Heart J 40:5 (2019), 476–484, 10.1093/eurheartj/ehy641.
Messika-Zeitoun, D., Verta, P., Gregson, J., et al. Impact of tricuspid regurgitation on survival in patients with heart failure: a large electronic health record patient-level database analysis. Eur J Heart Fail 22:10 (2020), 1803–1813, 10.1002/ejhf.1830.
Kar, S., Makkar, R.R., Whisenant, B.K., et al. Two-year outcomes of transcatheter edge-to-edge repair for severe tricuspid regurgitation: the TRILUMINATE pivotal randomized controlled trial. Circulation 151:23 (2025), 1630–1638, 10.1161/CIRCULATIONAHA.125.074536.
Hahn, R.T., Makkar, R., Thourani, V.H., et al., TRISCEND II Trial Investigators. Transcatheter valve replacement in severe tricuspid regurgitation. N Engl J Med 392:2 (2025), 115–126, 10.1056/NEJMoa2401918.
Colombo, A., Maisano, F., A new tool for the forgotten valve: a score to predict the risk of surgery. Eur Heart J 43:7 (2022), 663–665, 10.1093/eurheartj/ehab799.
Hochstadt, A., Maor, E., Ghantous, E., et al. A validated score to predict one-year and long-term mortality in patients with significant tricuspid regurgitation. Eur Heart J Open, 2(6), 2022, oeac067, 10.1093/ehjopen/oeac067.
Muraru, D., Petersen, S.E., Dweck, M.R., et al. EACVI survey on the current multi-modality imaging practice in patients with tricuspid regurgitation. Eur Heart J Imaging Methods Pract, 4(1), 2026, qyag008, 10.1093/ehjimp/qyag008.
Stolz, L., Orban, M., Besler, C., et al. Cardiohepatic syndrome is associated with poor prognosis in patients undergoing tricuspid transcatheter edge-to-edge valve repair. JACC Cardiovasc Interv 15:2 (2022), 179–189, 10.1016/j.jcin.2021.10.033.
Wild, M.G., Stolz, L., Rosch, S., et al., PASTE Investigators. Transcatheter valve repair for tricuspid regurgitation: 1-year results from a large European real-world registry. J Am Coll Cardiol 85:3 (2025), 220–231, 10.1016/j.jacc.2024.10.068.
Yanovskiy, A., Ojala, T., Kormi, A., Kivisaari, R., Peltonen, J., Martelius, L., Peripheral vs. central parametric mapping of the liver in single ventricle patients: measurement location matters. Eur J Radiol, 188, 2025, 112158, 10.1016/j.ejrad.2025.112158.
Margonato, D., Enriquez-Sarano, M., Fukui, M., et al. Lead-related tricuspid regurgitation: novel insights through the lens of computed tomography. JACC Cardiovasc Interv 18:10 (2025), 1351–1353, 10.1016/j.jcin.2025.02.010.
Dalos, D., Binder, C., Duca, F., et al. Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction. Sci Rep, 9(1), 2019, 18541, 10.1038/s41598-019-55116-8.